Christopher Garabedian - President and CEO, Sarepta Therapeutics, Inc

As of March 3, 2015


Christopher Garabedian Net Worth

  • Net worth is estimated to be at least $2.19M
  • Owns at least 29,552 units of Sarepta Therapeutics, Inc stock

Christopher Garabedian Trading

  • Largest purchase of shares was 800 units , worth over $9.45K on March 3, 2015
  • In total has made about 2 transactions over a year
  • Usually trades in March, with the busiest year in 2014 and 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Christopher Garabedian Mailing Address

  • Mailing address is 333 River Street #303 Hoboken NJ 07030 NJ

Sarepta Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Douglas S. Ingram 2020 $669,250 - $17,222 $17,222 $17,222 $1,291,947
Douglas S. Ingram 2019 $650,000 - $5,822 $5,822 $5,822 $1,387,072
Douglas S. Ingram 2018 $650,000 - $5,822 $5,822 $5,822 $1,433,872
Ian M. Estepan 2020 $445,822 $434,986 $32,744 $32,744 $32,744 $5,177,681
Ian M. Estepan 2019 - - - - - -
Ian M. Estepan 2018 - - - - - -
Gilmore O'Neill, M.B., M.M.Sc. 2020 $583,277 $766,949 $15,500 $15,500 $15,500 $3,790,049
Gilmore O'Neill, M.B., M.M.Sc. 2019 $563,962 - $15,300 $15,300 $15,300 $5,168,110
Gilmore O'Neill, M.B., M.M.Sc. 2018 $310,962 $1,154,760 $2,050 $2,050 $2,050 $6,449,176
William Ciambrone 2020 $458,179 - $14,500 $14,500 $14,500 $679,938
William Ciambrone 2019 $51,346 - $1,000 $1,000 $1,000 $4,345,194
William Ciambrone 2018 - - - - - -
Louise Rodino-Klapac, Ph.D. 2020 $495,590 $766,949 $13,532 $13,532 $13,532 $7,269,509
Louise Rodino-Klapac, Ph.D. 2019 - - - - - -
Louise Rodino-Klapac, Ph.D. 2018 - - - - - -
Joseph Bratica 2020 $326,028 $237,525 $11,645 $11,645 $11,645 $911,887
Joseph Bratica 2019 - - - - - -
Joseph Bratica 2018 - - - - - -
Sandesh Mahatme 2020 $312,835 $766,949 $39,413 $39,413 $39,413 $3,364,021
Sandesh Mahatme 2019 $557,327 - $14,840 $14,840 $14,840 $5,161,209
Sandesh Mahatme 2018 $498,112 - $24,838 $24,838 $24,838 $4,219,084
David Tyronne Howton, Jr. 2020 $470,695 $1,050,929 $157,280 $157,280 $157,280 $5,703,078
David Tyronne Howton, Jr. 2019 $458,844 - $13,318 $13,318 $13,318 $4,196,622
David Tyronne Howton, Jr. 2018 $438,185 - $13,118 $13,118 $13,118 $3,129,375
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/873303/000156459021019631/srpt-def14a_20210603.htm

Sarepta Therapeutics, Inc Insider Trading

  • The most recent transaction was 5,000 units sold on March 10, 2021 by Kathleen Behrens worth over $428.8K
  • In the last 9 years, insiders at Sarepta Therapeutics, Inc sold an estimated value of $175.13M and bought an estimated value of $39.32M
  • The most active traders are Sandesh Mahatme, EVP,  David T Howton, EVP,  and Edward M. Kaye, Director
  • Insider trading is most common in March, with the busiest year in 2017

Sarepta Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1